CL
BIIB icon

CIM LLC’s Biogen BIIB Stock Holding History

CIM LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,165
Closed -$7.62M – 164
2020
Q3 		$7.62M Buy
23,165
+262
+1% +$73.1K 1.55% 22
2020
Q2 		$6.13M Buy
22,903
+82
+0.4% +$24.6K 1.8% 19
2020
Q1 		$7.22M Sell
22,821
-319
-1% -$96.8K 2.74% 19
2019
Q4 		$6.87M Sell
23,140
-53
-0.2% -$14.7K 2.15% 19
2019
Q3 		$5.4M Buy
23,193
+9,631
+71% +$2.24M 1.86% 21
2019
Q2 		$3.17M Sell
13,562
-14,486
-52% -$3.34M 1.09% 23
2019
Q1 		$6.63M Buy
28,048
+587
+2% +$185K 2.44% 18
2018
Q4 		$8.26M Buy
27,461
+375
+1% +$120K 3.61% 14
2018
Q3 		$9.57M Sell
27,086
-3,282
-11% -$1.13M 3.5% 12
2018
Q2 		$8.81M Buy
30,368
+2,507
+9% +$705K 3.18% 18
2018
Q1 		$7.63M Buy
27,861
+286
+1% +$88.8K 2.96% 17
2017
Q4 		$8.79M Buy
27,575
+82
+0.3% +$26.3K 3.44% 17
2017
Q3 		$8.61M Buy
27,493
+22
+0.1% +$6.51K 3.56% 14
2017
Q2 		$7.46M Sell
27,471
-135
-0.5% -$35.7K 3.19% 18
2017
Q1 		$7.55M Sell
27,606
-1,761
-6% -$498K 3.41% 17
2016
Q4 		$8.33M Buy
29,367
+1,383
+5% +$410K 4.18% 12
2016
Q3 		$8.76M Buy
27,984
+17,525
+168% +$5.19M 4.11% 9
2016
Q2 		$2.53M Sell
10,459
-14,836
-59% -$3.91M 1.26% 23
2016
Q1 		$6.58M Buy
25,295
+1,784
+8% +$471K 3.25% 20
2015
Q4 		$7.2M Buy
23,511
+664
+3% +$191K 3.5% 18
2015
Q3 		$6.67M Buy
22,847
+529
+2% +$175K 3.37% 19
2015
Q2 		$9.02M Buy
22,318
+613
+3% +$246K 4.27% 10
2015
Q1 		$9.16M Buy
+21,705
New +$8.55M 4.28% 8

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIM LLC's BIIB Position: Q4 2020 in Review

CIM LLC sold out of Biogen (BIIB) in Q4 2020, closing a stake of 23,165 shares — an estimated $7.62M sold.

CIM LLC first reported a position in BIIB in Q1 2015 and held it in 23 quarters. The position peaked at $9.57M in Q3 2018. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • CIM LLC reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • CIM LLC sold 23,165 Biogen shares in Q4 2020, an estimated $7.62M.
  • CIM LLC first reported a position in Biogen in Q1 2015 and held it in 23 quarters.
  • CIM LLC's Biogen position peaked at $9.57M in Q3 2018.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on CIM LLC's 13F filing for Q4 2020, filed 8 Feb 2021.